SAGA Diagnostics

SAGA Diagnostics is a cancer diagnostics company that specializes in providing ultrasensitive quantification of liquid biopsy biomarkers. Their proprietary MRD testing platform is designed to detect and intercept molecular residual disease (MRD) as early as possible for every patient. They utilize a unique, tumor-informed approach based on a hybrid of next-generation sequencing (NGS) and digital PCR technology, enabling them to track patient-specific structural variants (SVs) with exceptional sensitivity and specificity.

SAGA Diagnostics is committed to improving precision cancer medicine and providing more accurate treatment monitoring. Their mission is to help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at unprecedented sensitivity and scale. They are rapidly scaling their business and expanding their team of talented and driven individuals to achieve their mission.

SAGA Diagnostics offers a dynamic work environment with a focus on employee well-being. The company provides flexible working arrangements and a flat structure, which empowers employees to manage their time and responsibilities effectively. This fosters a sense of autonomy and allows for a healthy work-life balance, contributing to a positive and productive work culture.

SAGA Diagnostics offers a comprehensive benefits package to its employees, including competitive salaries, flexible working arrangements, a flat organizational structure, and a dynamic work environment. The company also provides the opportunity to build a critical clinical research portfolio from concept, the chance to help set the direction and culture as the company grows, and the autonomy and resources to perform at the highest level.

SAGA Diagnostics is a personalized cancer diagnostics company dedicated to revolutionizing cancer detection and monitoring through the use of liquid biopsies. Their mission is to improve precision cancer medicine, provide more accurate treatment monitoring, and ultimately improve patient survival by leveraging their ultrasensitive ctDNA testing services. This involves detecting actionable mutations, stratifying patient groups, and monitoring treatment response, residual disease, and recurrence with unprecedented sensitivity and scale.

SAGA Diagnostics cultivates a dynamic and collaborative work environment, embracing the values of teamwork, innovation, and a shared passion for advancing cancer diagnostics. The company prioritizes employee autonomy and provides a supportive and flexible work environment, attracting driven individuals who are eager to make a significant impact in the fight against cancer.

SAGA Diagnostics is committed to fostering a diverse, equitable, and inclusive workplace. They actively seek to create a culture where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents. This commitment is reflected in their recruitment practices, employee development programs, and company policies, which aim to promote equal opportunities for all individuals. SAGA recognizes the importance of diversity in driving innovation and excellence, and they strive to create a workplace where everyone feels a sense of belonging and can thrive.